Angélica Torres-Berrío, Orna Issler, Eric M Parise, Eric J Nestler
{"title":"Unraveling the epigenetic landscape of depression: focus on early life stress\u2029.","authors":"Angélica Torres-Berrío, Orna Issler, Eric M Parise, Eric J Nestler","doi":"10.31887/DCNS.2019.21.4/enestler","DOIUrl":null,"url":null,"abstract":"<p><p>Depression is a devastating psychiatric disorder caused by a combination of genetic predisposition and life events, mainly exposure to stress. Early life stress (ELS) in particular is known to \"scar\" the brain, leading to an increased susceptibility to developing depression later in life via epigenetic mechanisms. Epigenetic processes lead to changes in gene expression that are not due to changes in DNA sequence, but achieved via modulation of chromatin modifications, DNA methylation, and noncoding RNAs. Here we review common epigenetic mechanisms including the enzymes that take part in reading, writing, and erasing specific epigenetic marks. We then describe recent developments in understanding how ELS leads to changes in the epigenome that are manifested in increased susceptibility to depression-like abnormalities in animal models. We conclude with highlighting the need for future studies that will potentially enable the utilisation of the understanding of epigenetic changes linked to ELS for the development of much-needed novel therapeutic strategies and biomarker discovery.\u2029.</p>","PeriodicalId":54343,"journal":{"name":"Dialogues in Clinical Neuroscience","volume":null,"pages":null},"PeriodicalIF":8.3000,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/68/e9/DialoguesClinNeurosci-21-341.PMC6952747.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dialogues in Clinical Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.31887/DCNS.2019.21.4/enestler","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Depression is a devastating psychiatric disorder caused by a combination of genetic predisposition and life events, mainly exposure to stress. Early life stress (ELS) in particular is known to "scar" the brain, leading to an increased susceptibility to developing depression later in life via epigenetic mechanisms. Epigenetic processes lead to changes in gene expression that are not due to changes in DNA sequence, but achieved via modulation of chromatin modifications, DNA methylation, and noncoding RNAs. Here we review common epigenetic mechanisms including the enzymes that take part in reading, writing, and erasing specific epigenetic marks. We then describe recent developments in understanding how ELS leads to changes in the epigenome that are manifested in increased susceptibility to depression-like abnormalities in animal models. We conclude with highlighting the need for future studies that will potentially enable the utilisation of the understanding of epigenetic changes linked to ELS for the development of much-needed novel therapeutic strategies and biomarker discovery. .
抑郁症是一种毁灭性的精神疾病,由遗传易感性和生活事件(主要是面临的压力)共同造成。众所周知,早期生活压力(ELS)会给大脑留下 "疤痕",从而通过表观遗传机制增加日后患抑郁症的几率。表观遗传过程会导致基因表达的改变,而这些改变并不是由于 DNA 序列的改变,而是通过染色质修饰、DNA 甲基化和非编码 RNA 的调节实现的。在此,我们回顾了常见的表观遗传机制,包括参与读取、书写和清除特定表观遗传标记的酶。然后,我们将介绍在了解 ELS 如何导致表观基因组变化方面的最新进展,这些变化在动物模型中表现为抑郁症样异常的易感性增加。最后,我们强调了未来研究的必要性,这些研究将有可能利用对与 ELS 相关的表观遗传变化的了解来开发急需的新型治疗策略和发现生物标志物。.
期刊介绍:
Dialogues in Clinical Neuroscience (DCNS) endeavors to bridge the gap between clinical neuropsychiatry and the neurosciences by offering state-of-the-art information and original insights into pertinent clinical, biological, and therapeutic aspects. As an open access journal, DCNS ensures accessibility to its content for all interested parties. Each issue is curated to include expert reviews, original articles, and brief reports, carefully selected to offer a comprehensive understanding of the evolving landscape in clinical neuroscience. Join us in advancing knowledge and fostering dialogue in this dynamic field.